Progress Is Being Made Toward Approval Of Generic Biotechnology Drugs
Dec 6th 2007Drug InformationPharma Industry
The U.S. slowly is making progress toward developing a regulatory pathway that would allow FDA to approve generic versions of biotechnology drugs, experts from the generic drug industry told attendees of the 10th annual International Generic Pharmaceutical Alliance conference in Miami Beach on Thursday, the [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
